You are currently viewing a new version of our website. To view the old version click .
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 19, Issue 11

June 2012 - 21 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (21)

  • Review
  • Open Access
38 Citations
1,400 Views
9 Pages

1 December 2012

Purpose: Intermittent androgen deprivation is increasingly used as an alternative to continuous life-long androgen deprivation therapy for men with advanced or recurrent prostate cancer. Recent Findings: Two recent phase III trials have clarified the...

  • Review
  • Open Access
37 Citations
1,960 Views
10 Pages

1 December 2012

Since the year 2000, tremendous progress has been made in the understanding of castration-resistant prostate cancer (CRPC), a disease state now recognized to retain androgen receptor (AR)—dependency in most cases. That understanding led to the ration...

  • Review
  • Open Access
4 Citations
710 Views
5 Pages

1 December 2012

Treatment options for castration-resistant prostate cancer (CRPC) have evolved since the start of the 2000s, with most of the new effective therapies appearing since 2010. In 2004, docetaxel was the first chemotherapeutic agent to improve survival in...

  • Review
  • Open Access
58 Citations
1,709 Views
8 Pages

1 December 2012

The number of prostate cancer survivors is rapidly growing in the Western world. As a result of better oncologic outcomes, more patients are living longer with the adverse effects of treatment, which can be both functional and psychological. Clinicia...

  • Review
  • Open Access
6 Citations
785 Views
7 Pages

1 December 2012

Prostate cancer is a common malignancy worldwide, and in Canada, it is the most frequently diagnosed cancer in men. The stratification of prostate cancer into risk categories has allowed for improved counselling of patients and provides guidance for...

  • Article
  • Open Access
37 Citations
1,344 Views
9 Pages

1 July 2012

Objective: Many scientific studies have shown that Asparagus officinalis has an antitumour effect and enhances human immunity, but the active components and the antitumour mechanisms are unclear. We investigated the effects of saponins isolated from...

  • Article
  • Open Access
9 Citations
868 Views
5 Pages

1 July 2012

Background: Patients with malignant ascites (MA) usually experience poor quality of life, and treatment of this symptom remains a challenge. Oxidative stress, which can cause oxidative damage to DNA, plays a pivotal role in carcinogenesis; however, t...

  • Article
  • Open Access
5 Citations
965 Views
7 Pages

1 July 2012

Background and Objectives: The present study evaluated the potential role of lysophosphatidic acid receptors (LPARS) in processes leading to local invasiveness and metastasis in Chinese pancreatic carcinoma. Methods: Real-time reverse-transcriptase p...

  • Article
  • Open Access
16 Citations
1,310 Views
9 Pages

Combined Performance of Physical Examination, Mammography, and Ultrasonography for Breast Cancer Screening among Chinese Women: A Follow-Up study

  • Y. Huang,
  • M. Kang,
  • H. Li,
  • J.Y. Li,
  • J.Y. Zhang,
  • L.H. Liu,
  • X.T. Liu,
  • Y. Zhao,
  • Q. Wang and
  • C.C. Li
  • + 1 author

1 July 2012

PE vte Objective: We aimed to determine which combination of physical examination (PE), mammography (MAM), and ultrasonography (US) would optimize breast cancer detection in China. Methods: We conducted a trial of screening with pe, mam, and us among...

of 3

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729